financetom
Business
financetom
/
Business
/
Honeywell Poised for Q2 Beat, 'Decent' Q3 Outlook, BofA Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Honeywell Poised for Q2 Beat, 'Decent' Q3 Outlook, BofA Says
Jul 14, 2025 10:38 AM

01:20 PM EDT, 07/14/2025 (MT Newswires) -- Honeywell International ( HON ) is "well-positioned" to report a beat-and-raise during its Q2 earnings and provide "decent" Q3 guidance that brackets consensus, BofA Securities said in an earnings preview Monday.

The brokerage said it expects any positive revisions to guidance to drive Honeywell ( HON ) shares higher, noting that the stock still trades at a discount to its peers.

The investment firm highlighted that Honeywell's ( HON ) conservative outlook for 2025 now looks increasingly cautious given recent macro and channel checks.

"We think short-cycle collapse is unlikely," BofA said, adding that its intra-quarter meetings with the company indicated broad confidence in the business.

Regarding Honeywell's ( HON ) recent mergers, acquisitions and divestitures, BofA estimated these actions have structurally added about 70 basis points of growth to the overall Honeywell ( HON ) portfolio and 110 basis points to the Honeywell Automation segment.

For Q2, BofA expects earnings per share of $2.65, reflecting 1.7% organic growth and a 10 basis-point margin contraction, mainly driven by aerospace integration.

The firm maintained its buy rating on Honeywell ( HON ) and raised its price objective to $275 from $250, citing an undemanding valuation relative to industrial peers.

Price: 238.04, Change: +2.11, Percent Change: +0.89

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Paylocity Holding Insider Sold Shares Worth $4,138,007, According to a Recent SEC Filing
Paylocity Holding Insider Sold Shares Worth $4,138,007, According to a Recent SEC Filing
Dec 16, 2024
04:17 PM EST, 12/16/2024 (MT Newswires) -- Steven I Sarowitz, 10% Owner, Director, on December 12, 2024, sold 20,421 shares in Paylocity Holding ( PCTY ) for $4,138,007. Following the Form 4 filing with the SEC, Sarowitz has control over a total of 8,885,533 shares of the company, with 8,365,533 shares held directly and 520,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1591698/000159169824000427/xslF345X05/wk-form4_1734383554.xml...
Mama's Creations Fiscal Q3 Earnings Decline, Revenue Increases; Shares Plunge After Hours
Mama's Creations Fiscal Q3 Earnings Decline, Revenue Increases; Shares Plunge After Hours
Dec 16, 2024
04:22 PM EST, 12/16/2024 (MT Newswires) -- Mama's Creations (MAMA) reported fiscal Q3 diluted earnings late Monday of $0.01 per share, down from $0.05 a year earlier. A single analyst surveyed by FactSet expected $0.03. Revenue for the quarter ended Oct. 31 was $31.5 million, up from $28.7 million a year earlier. Four analysts surveyed by FactSet expected $30 million....
Merus Reports First Person Dosed in Mid-Stage Petosemtamab Trial
Merus Reports First Person Dosed in Mid-Stage Petosemtamab Trial
Dec 16, 2024
04:22 PM EST, 12/16/2024 (MT Newswires) -- Merus (MRUS) said Monday the first person has been dosed in its phase 2 trial assessing petosemtamab in heavily pretreated metastatic colorectal cancer. In preclinical CRC models, petosemtamab consistently demonstrates superior activity compared to cetuximab, a mainstay therapy in mCRC, said Merus Chief Technology Officer John de Kruif. ...
Lyondellbasell Industries Insider Bought Shares Worth $380,300, According to a Recent SEC Filing
Lyondellbasell Industries Insider Bought Shares Worth $380,300, According to a Recent SEC Filing
Dec 16, 2024
04:17 PM EST, 12/16/2024 (MT Newswires) -- Robin W.T. Buchanan, Director, on December 13, 2024, executed a purchase for 5,000 shares in Lyondellbasell Industries ( LYB ) for $380,300. Following the Form 4 filing with the SEC, Buchanan has control over a total of 18,175 shares of the company, with 18,175 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1489393/000156218024008417/xslF345X05/primarydocument.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved